Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Primary Care
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Community Practice
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign In
or
Register
to read more
11392
Related Questions
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
How do you counsel patients/families whose goals of care are clearly aligned with a comfort-focused, end-of-life approach, but who are hesitant to formally enroll in hospice?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
In what patients is it inappropriate to offer DCISionRT testing?
Does delay to the time of lumpectomy impact your decision to omit radiation?